Category Press Releases

View current press releases, to submit a press release please contact [email protected] for pricing.

Interim Report Q3 2023

The Interim Report for the 3rd Quarter 2023 for A.P. Møller – Mærsk A/S is hereby enclosed. CEO of A.P. Møller – Mærsk A/S, Søren Skou, states: “In the ongoing exceptional market situation, with high demand in the US and…

PD-1/VEGF Bi-Specific Antibody (AK112) Obtained Approval to Initiate a Phase II Clinical Trial for Monotherapy or Combined Chemotherapy Neoadjuvant/Adjuvant Therapy of Resectable Non-Small Cell Lung Cancer

HONG KONG, Nov. 2, 2023 /PRNewswire/ — Akeso, Inc. (the Company, 9926.HK) announces that AK112 (PD-1/VEGF bi-specific antibody), the novel immuno-oncology drug independently developed by the Company, obtained approval from the Center for Drug Evaluation (CDE) of the National Medical…

Press Release

This press release is issued pursuant to National Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE…